Form 4: Tenax Therapeutics Insider Buys Shares
Insider Transaction (Form 4)
ADAR1 Capital Management, LLC and 1 other reported changes in beneficial ownership of Tenax Therapeutics, Inc. common stock on August 31, 2026.
Summary
- Open-market purchase: acquired 403,571 Common Stock at $1.79 ($722,594) on August 31, 2026; holds 5,257,389 after (Indirect).
- Open-market purchase: acquired 179,058 Common Stock at $1.80 ($321,570) on September 1, 2026; holds 5,436,447 after (Indirect).
- Open-market purchase: acquired 187,704 Common Stock at $1.80 ($337,586) on September 2, 2026; holds 5,624,151 after (Indirect).
Sentiment
Score: 9
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $1,381,750, committing personal capital to the stock.
Insider Transactions
ADAR1 Capital Management, LLC — 10% owner
Daniel Schneeberger — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-31 | Open-market purchase | Common Stock | 403,571 | $2 | $722.6K | 5,257,389 |
| 2026-09-01 | Open-market purchase | Common Stock | 179,058 | $2 | $321.6K | 5,436,447 |
| 2026-09-02 | Open-market purchase | Common Stock | 187,704 | $2 | $337.6K | 5,624,151 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-31 | Open-market purchase (403,571 shares) |
| 2026-09-01 | Open-market purchase (179,058 shares) |
| 2026-09-02 | Open-market purchase (187,704 shares) |
Keywords
insider transaction, Form 4, TENX, TENAX THERAPEUTICS, INC., bullish, ADAR1 Capital Management, LLC, Daniel Schneeberger
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.